WO2004050986A1 - A process for obtaining a cellulosic wet sheet and a membrane the equipment used to obtain the membrane and the membrane obtained. - Google Patents
A process for obtaining a cellulosic wet sheet and a membrane the equipment used to obtain the membrane and the membrane obtained. Download PDFInfo
- Publication number
- WO2004050986A1 WO2004050986A1 PCT/BR2003/000174 BR0300174W WO2004050986A1 WO 2004050986 A1 WO2004050986 A1 WO 2004050986A1 BR 0300174 W BR0300174 W BR 0300174W WO 2004050986 A1 WO2004050986 A1 WO 2004050986A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wet sheet
- membrane
- wet
- process used
- fact
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 74
- 239000012528 membrane Substances 0.000 title claims abstract description 73
- 230000008569 process Effects 0.000 title claims abstract description 62
- 239000000463 material Substances 0.000 claims abstract description 43
- 238000001035 drying Methods 0.000 claims abstract description 33
- 230000002745 absorbent Effects 0.000 claims abstract description 25
- 239000002250 absorbent Substances 0.000 claims abstract description 25
- 238000000855 fermentation Methods 0.000 claims abstract description 21
- 230000004151 fermentation Effects 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000001963 growth medium Substances 0.000 claims abstract description 19
- 150000001875 compounds Chemical class 0.000 claims abstract description 12
- 239000002054 inoculum Substances 0.000 claims abstract description 6
- 238000005406 washing Methods 0.000 claims abstract description 6
- 238000010438 heat treatment Methods 0.000 claims abstract description 5
- 238000001816 cooling Methods 0.000 claims abstract description 4
- 239000000047 product Substances 0.000 claims description 29
- 229920002678 cellulose Polymers 0.000 claims description 28
- 239000001913 cellulose Substances 0.000 claims description 28
- 235000010980 cellulose Nutrition 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 28
- 206010052428 Wound Diseases 0.000 claims description 18
- 208000027418 Wounds and injury Diseases 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 18
- 238000011282 treatment Methods 0.000 claims description 14
- 239000010935 stainless steel Substances 0.000 claims description 13
- 229910001220 stainless steel Inorganic materials 0.000 claims description 13
- 210000001519 tissue Anatomy 0.000 claims description 13
- 239000007789 gas Substances 0.000 claims description 11
- 239000002609 medium Substances 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 210000001724 microfibril Anatomy 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 6
- 238000001727 in vivo Methods 0.000 claims description 6
- 230000035699 permeability Effects 0.000 claims description 6
- 230000008929 regeneration Effects 0.000 claims description 6
- 238000011069 regeneration method Methods 0.000 claims description 6
- 239000003381 stabilizer Substances 0.000 claims description 6
- 239000002562 thickening agent Substances 0.000 claims description 6
- 244000235858 Acetobacter xylinum Species 0.000 claims description 5
- 235000002837 Acetobacter xylinum Nutrition 0.000 claims description 5
- 208000025865 Ulcer Diseases 0.000 claims description 4
- 229940041514 candida albicans extract Drugs 0.000 claims description 4
- 235000009508 confectionery Nutrition 0.000 claims description 4
- 230000002500 effect on skin Effects 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 231100000397 ulcer Toxicity 0.000 claims description 4
- 239000012138 yeast extract Substances 0.000 claims description 4
- 230000000172 allergic effect Effects 0.000 claims description 3
- 208000010668 atopic eczema Diseases 0.000 claims description 3
- 238000011109 contamination Methods 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 230000007246 mechanism Effects 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- 210000004080 milk Anatomy 0.000 claims description 3
- 230000000717 retained effect Effects 0.000 claims description 3
- 239000004576 sand Substances 0.000 claims description 3
- 229910000975 Carbon steel Inorganic materials 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 229910000831 Steel Inorganic materials 0.000 claims description 2
- 239000011358 absorbing material Substances 0.000 claims description 2
- 230000001464 adherent effect Effects 0.000 claims description 2
- 238000013019 agitation Methods 0.000 claims description 2
- 230000004888 barrier function Effects 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims description 2
- 239000000560 biocompatible material Substances 0.000 claims description 2
- 239000010962 carbon steel Substances 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 235000013861 fat-free Nutrition 0.000 claims description 2
- 239000011152 fibreglass Substances 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 230000002439 hemostatic effect Effects 0.000 claims description 2
- 230000000813 microbial effect Effects 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 150000002825 nitriles Chemical class 0.000 claims description 2
- 230000000474 nursing effect Effects 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 235000013324 preserved food Nutrition 0.000 claims description 2
- 238000011084 recovery Methods 0.000 claims description 2
- 230000004044 response Effects 0.000 claims description 2
- 238000007493 shaping process Methods 0.000 claims description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 239000010959 steel Substances 0.000 claims description 2
- 235000000346 sugar Nutrition 0.000 claims description 2
- 230000008719 thickening Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 1
- 238000001291 vacuum drying Methods 0.000 claims 1
- 229920002749 Bacterial cellulose Polymers 0.000 abstract description 9
- 239000005016 bacterial cellulose Substances 0.000 abstract description 9
- 239000000126 substance Substances 0.000 abstract description 8
- 230000018044 dehydration Effects 0.000 abstract description 5
- 238000006297 dehydration reaction Methods 0.000 abstract description 5
- 238000000746 purification Methods 0.000 abstract description 5
- 230000002087 whitening effect Effects 0.000 abstract description 5
- 239000007864 aqueous solution Substances 0.000 abstract description 2
- 238000009418 renovation Methods 0.000 abstract description 2
- 239000004744 fabric Substances 0.000 description 21
- 238000003556 assay Methods 0.000 description 13
- 238000003825 pressing Methods 0.000 description 13
- 210000003491 skin Anatomy 0.000 description 13
- 238000012360 testing method Methods 0.000 description 9
- 238000005259 measurement Methods 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 8
- 239000002184 metal Substances 0.000 description 8
- 230000017423 tissue regeneration Effects 0.000 description 8
- 230000003902 lesion Effects 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 206010072170 Skin wound Diseases 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 235000013681 dietary sucrose Nutrition 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 229960004793 sucrose Drugs 0.000 description 3
- 108010023728 Alloderm Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- BFCXCFJUDBNEMU-QPIZCGMOSA-N Clovin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 BFCXCFJUDBNEMU-QPIZCGMOSA-N 0.000 description 2
- 108010049003 Fibrinogen Proteins 0.000 description 2
- 102000008946 Fibrinogen Human genes 0.000 description 2
- 241000446313 Lamella Species 0.000 description 2
- BFCXCFJUDBNEMU-MOXICKDUSA-N Quercetin 3-robinobioside-7-rhamnoside Natural products O(C[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](OC2=C(c3cc(O)c(O)cc3)Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O4)c3)C2=O)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O1 BFCXCFJUDBNEMU-MOXICKDUSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229940012952 fibrinogen Drugs 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- BFCXCFJUDBNEMU-UHFFFAOYSA-N quercetin 7-O-alpha-L-rhamnoside 3-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(OC4C(C(O)C(O)C(C)O4)O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 BFCXCFJUDBNEMU-UHFFFAOYSA-N 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 235000020374 simple syrup Nutrition 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010006803 Burns third degree Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 241000324343 Causa Species 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010056340 Diabetic ulcer Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 241001602876 Nata Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 241000304405 Sedum burrito Species 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000018756 Variant Creutzfeldt-Jakob disease Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 208000005881 bovine spongiform encephalopathy Diseases 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 235000020415 coconut juice Nutrition 0.000 description 1
- 235000020197 coconut milk Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000005008 domestic process Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000012027 fruit salads Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- -1 polytetrafluorethylen Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 201000002282 venous insufficiency Diseases 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21C—PRODUCTION OF CELLULOSE BY REMOVING NON-CELLULOSE SUBSTANCES FROM CELLULOSE-CONTAINING MATERIALS; REGENERATION OF PULPING LIQUORS; APPARATUS THEREFOR
- D21C5/00—Other processes for obtaining cellulose, e.g. cooking cotton linters ; Processes characterised by the choice of cellulose-containing starting materials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/06—Flat membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/08—Polysaccharides
- B01D71/10—Cellulose; Modified cellulose
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Definitions
- Figure 5 Outline of the covered fermentation tray with temperature controlled by the circulation of liquids; this figure is composed of figure 5a - The tray without its covering seen from above, and 5b - transverse section of the tray (with the covering);
- the membranes can also be used as diaphragm in the production of speakers and earphones.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Materials For Medical Uses (AREA)
- Nonwoven Fabrics (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03773361A EP1570124A1 (en) | 2002-12-05 | 2003-11-26 | A process for obtaining a cellulosic wet sheet and a membrane, the equipment used to obtain the membrane and the membrane obtained |
US10/538,131 US20060134758A1 (en) | 2002-12-05 | 2003-11-26 | Process for obtaining a ccellulosic wet sheet and a membrane, the equipment used to obtain the membrane and the membrane obtained |
AU2003283089A AU2003283089A1 (en) | 2002-12-05 | 2003-11-26 | A process for obtaining a cellulosic wet sheet and a membrane the equipment used to obtain the membrane and the membrane obtained. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0205499-0 | 2002-12-05 | ||
BR0205499-0A BR0205499A (en) | 2002-12-05 | 2002-12-05 | Process for obtaining mat and cellulosic membrane, process for obtaining matted cellulosic that incorporates other materials, culture medium used, closed fermentation trays, drying equipment used, cellulose membrane obtained by such process and uses of said matting and membranes |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004050986A1 true WO2004050986A1 (en) | 2004-06-17 |
Family
ID=32399291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/BR2003/000174 WO2004050986A1 (en) | 2002-12-05 | 2003-11-26 | A process for obtaining a cellulosic wet sheet and a membrane the equipment used to obtain the membrane and the membrane obtained. |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1570124A1 (en) |
AU (1) | AU2003283089A1 (en) |
BR (1) | BR0205499A (en) |
WO (1) | WO2004050986A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006066377A1 (en) * | 2004-12-22 | 2006-06-29 | Bionext Produtos Biotecnológicos Ltda. | Continuous fermentation process to produce bacterial cellulosic sheets |
DE102008046298A1 (en) | 2008-09-09 | 2010-03-11 | Epc Engineering Consulting Gmbh | Apparatus for the production of bacterially synthesized cellulose or cellulose-containing sheet material |
DE102008046644A1 (en) | 2008-09-09 | 2010-03-11 | Friedrich-Schiller-Universität Jena | Process for the production of bacterially synthesized cellulose and cellulosic material in a flat form |
CN102008902A (en) * | 2010-10-13 | 2011-04-13 | 天津大学 | Bacterial cellulose-inorganic nanoparticle hybrid membrane and preparation method thereof |
DE102010050311A1 (en) | 2010-11-03 | 2012-05-03 | Bsn Medical Gmbh | Wound dressing with a biocellulose layer that adsorbs bacteria |
DE102013001002A1 (en) | 2013-01-15 | 2014-07-17 | Friedrich-Schiller-Universität Jena | Producing homogeneous biotechnologically derived nanocellulose and cellulose-containing material in sheet form, comprises inoculating bacterial culture in culture vessel, feeding the air continuously and removing culture from vessel |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986002095A1 (en) * | 1984-10-01 | 1986-04-10 | Bio Fill Industria E Comercio De Produtos Medico H | Process for the preparation of cellulose film, cellulose film produced thereby, artificial skin graft and its use |
EP0206830A2 (en) * | 1985-06-27 | 1986-12-30 | Johnson & Johnson Products Inc. | Microbial polysaccharide articles and methods of production |
US4942128A (en) * | 1987-03-06 | 1990-07-17 | Board Of Regents, The University Of Texas System | Microbial cellulose modified during synthesis |
JPH0369A (en) * | 1989-05-29 | 1991-01-07 | Ajinomoto Co Inc | Body tissue coalescence preventing film |
US5846213A (en) * | 1997-06-16 | 1998-12-08 | The University Of Western Ontario | Cellulose membrane and method for manufacture thereof |
JP3468544B2 (en) * | 1993-04-20 | 2003-11-17 | 日本たばこ産業株式会社 | Method for producing edible cellulose |
-
2002
- 2002-12-05 BR BR0205499-0A patent/BR0205499A/en not_active Application Discontinuation
-
2003
- 2003-11-26 AU AU2003283089A patent/AU2003283089A1/en not_active Abandoned
- 2003-11-26 WO PCT/BR2003/000174 patent/WO2004050986A1/en not_active Application Discontinuation
- 2003-11-26 EP EP03773361A patent/EP1570124A1/en not_active Withdrawn
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986002095A1 (en) * | 1984-10-01 | 1986-04-10 | Bio Fill Industria E Comercio De Produtos Medico H | Process for the preparation of cellulose film, cellulose film produced thereby, artificial skin graft and its use |
US4912049A (en) * | 1984-10-01 | 1990-03-27 | Bio Fill Produtos Biotechnologicos S.A. | Process for the preparation of cellulose film, cellulose film produced thereby, artificial skin graft and its use |
EP0206830A2 (en) * | 1985-06-27 | 1986-12-30 | Johnson & Johnson Products Inc. | Microbial polysaccharide articles and methods of production |
US4942128A (en) * | 1987-03-06 | 1990-07-17 | Board Of Regents, The University Of Texas System | Microbial cellulose modified during synthesis |
JPH0369A (en) * | 1989-05-29 | 1991-01-07 | Ajinomoto Co Inc | Body tissue coalescence preventing film |
JP3468544B2 (en) * | 1993-04-20 | 2003-11-17 | 日本たばこ産業株式会社 | Method for producing edible cellulose |
US5846213A (en) * | 1997-06-16 | 1998-12-08 | The University Of Western Ontario | Cellulose membrane and method for manufacture thereof |
Non-Patent Citations (2)
Title |
---|
DATABASE WPI Section Ch Week 199107, Derwent World Patents Index; Class D16, AN 1991-047910, XP002274357 * |
DATABASE WPI Section Ch Week 200382, Derwent World Patents Index; Class D13, AN 1995-018278, XP002274358 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006066377A1 (en) * | 2004-12-22 | 2006-06-29 | Bionext Produtos Biotecnológicos Ltda. | Continuous fermentation process to produce bacterial cellulosic sheets |
DE102008046298A1 (en) | 2008-09-09 | 2010-03-11 | Epc Engineering Consulting Gmbh | Apparatus for the production of bacterially synthesized cellulose or cellulose-containing sheet material |
DE102008046644A1 (en) | 2008-09-09 | 2010-03-11 | Friedrich-Schiller-Universität Jena | Process for the production of bacterially synthesized cellulose and cellulosic material in a flat form |
WO2010029044A2 (en) | 2008-09-09 | 2010-03-18 | Epc Engineering Consulting Gmbh | Apparatus for the production of bacterially synthesized cellulose or cellulose-containing planar material |
WO2010029044A3 (en) * | 2008-09-09 | 2011-02-24 | Epc Engineering Consulting Gmbh | Apparatus for the production of bacterially synthesized cellulose or cellulose-containing planar material |
DE102008046298B4 (en) | 2008-09-09 | 2024-09-12 | EPC Engineering & Technologies GmbH | Reaction air treatment plant |
CN102008902A (en) * | 2010-10-13 | 2011-04-13 | 天津大学 | Bacterial cellulose-inorganic nanoparticle hybrid membrane and preparation method thereof |
DE102010050311A1 (en) | 2010-11-03 | 2012-05-03 | Bsn Medical Gmbh | Wound dressing with a biocellulose layer that adsorbs bacteria |
WO2012059488A1 (en) | 2010-11-03 | 2012-05-10 | Bsn Medical Gmbh | Wound dressing comprising a biocellulose layer having a bacteria-adsorbing design |
US9987170B2 (en) | 2010-11-03 | 2018-06-05 | Bsn Medical Gmbh | Wound dressing including a biocelulose layer having a bacteria-adsorbing design |
DE102013001002A1 (en) | 2013-01-15 | 2014-07-17 | Friedrich-Schiller-Universität Jena | Producing homogeneous biotechnologically derived nanocellulose and cellulose-containing material in sheet form, comprises inoculating bacterial culture in culture vessel, feeding the air continuously and removing culture from vessel |
Also Published As
Publication number | Publication date |
---|---|
AU2003283089A1 (en) | 2004-06-23 |
BR0205499A (en) | 2004-08-03 |
EP1570124A1 (en) | 2005-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5535446B2 (en) | Surgical device for skin treatment or examination | |
JPH0636815B2 (en) | Method for producing cellulose film as a substitute for artificial film | |
JP3423330B2 (en) | Non-porous collagen sheet for therapy and method and apparatus for preparing the same | |
AU2021245207A1 (en) | Human placental tissue graft products, methods, and apparatuses | |
EP1356831B1 (en) | Microbial cellulose wound dressing for treating chronic wounds | |
CN107233613A (en) | A kind of aquatic origin cross-linked collagen composite multi-layer medical dressing | |
AU2002309898A1 (en) | EB matrix production from fetal tissues and its use for tissue repair | |
Osorio et al. | Bioactive 3D‐Shaped Wound Dressings Synthesized from Bacterial Cellulose: Effect on Cell Adhesion of Polyvinyl Alcohol Integrated In Situ | |
WO2019084357A1 (en) | Cellulose membranes exhibiting high transparency and tensile elasticity | |
WO2004050986A1 (en) | A process for obtaining a cellulosic wet sheet and a membrane the equipment used to obtain the membrane and the membrane obtained. | |
CN103418018A (en) | Tea fungus synthesized bacterial cellulose pressure sore dressing as well as preparation method and application thereof | |
US20060134758A1 (en) | Process for obtaining a ccellulosic wet sheet and a membrane, the equipment used to obtain the membrane and the membrane obtained | |
CN100384485C (en) | microbial cellulose wound dressing for treating chronic wounds | |
CN101869516B (en) | Bacterial cellulose ice pack and production method thereof | |
Cheng et al. | A novel lamellar structural biomaterial and its effect on bone regeneration | |
WO2012003640A1 (en) | Membrane of biological fibers, and use thereof | |
CN112057667A (en) | Degradable and absorbable biological hemostatic material | |
Osorio et al. | Research Article Bioactive 3D-Shaped Wound Dressings Synthesized from Bacterial Cellulose: Effect on Cell Adhesion of Polyvinyl Alcohol Integrated In Situ | |
EP3124055A1 (en) | Biological fiber membrane and method for preparing the same | |
JPH04129563A (en) | Artificial skin and its manufacture | |
Jiang et al. | A superelastic, biofluid-locking, and degradable dressing for wound healing | |
BRPI0901688A2 (en) | process and trays for obtaining high purity activated bacterial cellulose mat and resulting products | |
JPH0618582B2 (en) | Artificial skin | |
RU2006124648A (en) | METHOD FOR TREATING BURN RAS | |
EP1414368A2 (en) | Eb matrix production from fetal tissues and its use for tissue repair |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003773361 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003773361 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2006134758 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10538131 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10538131 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |